JPRN-UMIN000003408
Completed
N/A
A clinical trial for evaluating diagnostic utility of magnified endoscopic examination with narrow band imaging (NBI) for reddish depressive lesion in stomach - Endoscopic diagnosis for gastric reddish depressive lesion by NBI
First Department of Internal Medicine, Sapporo Medical University School of Medicine0 sites752 target enrollmentApril 1, 2010
ConditionsReddish depressive lesion in stomach
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Reddish depressive lesion in stomach
- Sponsor
- First Department of Internal Medicine, Sapporo Medical University School of Medicine
- Enrollment
- 752
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Lesions already diagnosed before the study 2\. Obvious carcinoma 3\. Non\-epithelial tumor 4\. Lesions which cannot be biopsied (e.g. because recipients receive anti\-platelet therapy) 5\. Lesions which cannot be pathologically diagnosed (e.g. because specimen is too small to be diagnosed" 6\. Lesions detected by trans\-nasal upper gastrointestinal endoscopy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Diferent doses of lactase in subjects with intolerance lactoseRBR-53hjzkutracom Indústria e Comércio Ltda.
Active, Not Recruiting
N/A
Testing a food supplement in improving strength, power and mental alertnessHealthy volunteerNot ApplicableISRCTN86507492Farmaceutici Procemsa S.p.A.60
Active, Not Recruiting
N/A
Clinical trial to investigate clinical efficacy and tolerability of Tretinoin in actinic keratosis - Tretinoin bei AKactinic keratosisMedDRA version: 9.1Level: LLTClassification code 10000614Term: Actinic keratosisEUCTR2007-000093-23-DEAlmirall Hermal GmbH
Active, Not Recruiting
N/A
Clinical trial to investigate clinical efficacy and tolerability of Verrumal in actinic keratosis (PoC) - Verrumal in AKEUCTR2006-005432-24-DEHermal Kurt Herrmann GmbH & Co OHG15
Active, Not Recruiting
Phase 1
Pragmatic clinical trial of hydroxychloroquine in the treatment of oncohematological patients and health professionals with COVID-19 infection without radiological alteration.EUCTR2020-001765-37-ESInstitut Català d’Oncologia103